Synaptiq is a Romanian medtech startup founded in 2020 that develops Mediq, an AI-powered software for automated tumor and organs-at-risk contouring in radiotherapy. Mediq can contour 60+ organs across all cancer sites at human-level accuracy or higher and reduces contouring time from up to four hours to as little as five minutes. The software has been implemented and is being tested in eight radiotherapy clinics and was developed in-house after participation in the BCR-InnovX accelerator. In its first year the company raised a €250K pre-seed and received a €158K grant from Innovation Norway; it later launched a SeedBlink campaign targeting €600K that reached €650K. Investors in the recent activity include previous backers Cleverage VC and GapMinder VC, with Fortech Investments joining as lead. Synaptiq will use the latest funding to complete clinical trials required for CE marking (medical device risk class 2a) and plans to pursue FDA clearance and U.S. expansion in H2 2023. The company emphasizes patient safety and measured AI adoption while aiming to accelerate treatment planning and improve contouring quality.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

May 2023